Literature DB >> 31999141

Commentary on special issue on individual placement and support (IPS) international.

Deborah R Becker1, Gary R Bond1.   

Abstract

OBJECTIVE: In this commentary, we identify major themes found in this set of 11 articles, which examine the history of individual placement and support (IPS) adoption within each nation.
METHOD: We summarize major barriers and strategies to achieve to IPS adoption and implementation and briefly discuss IPS research conducted in these countries.
FINDINGS: Faced with many barriers, countries are developing strategies to promote IPS implementation and dissemination. IPS research has consistently found superior employment outcomes for people receiving IPS compared to usual services. Researchers are evaluating the effectiveness of IPS for new populations. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: IPS is expanding worldwide, aided by strong leadership, national directives, and the International IPS Learning Community. (PsycINFO Database Record (c) 2020 APA, all rights reserved).

Entities:  

Year:  2020        PMID: 31999141     DOI: 10.1037/prj0000402

Source DB:  PubMed          Journal:  Psychiatr Rehabil J        ISSN: 1095-158X


  3 in total

1.  International growth of individual placement and support.

Authors:  G R Bond; H Lockett; J van Weeghel
Journal:  Epidemiol Psychiatr Sci       Date:  2020-11-13       Impact factor: 6.892

2.  Implementing individual placement and support (IPS): the experiences of employment specialists in the early implementation phase of IPS in Northern Norway. The IPSNOR study.

Authors:  Cathrine Moe; Beate Brinchmann; Line Rasmussen; Oda Lekve Brandseth; David McDaid; Eóin Killackey; Miles Rinaldi; Marit Borg; Arnstein Mykletun
Journal:  BMC Psychiatry       Date:  2021-12-20       Impact factor: 3.630

3.  Assessing stable validity and reliability of the Japanese version of the individualized supported employment fidelity scale: A replication.

Authors:  Sosei Yamaguchi; Sayaka Sato; Yasutaka Ojio; Takuma Shiozawa; Asami Matsunaga; Ayano Taneda; Utako Sawada; Koji Yoshida; Chiyo Fujii
Journal:  Neuropsychopharmacol Rep       Date:  2021-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.